Erratum to Combination MET- And EGFR-directed Therapy in MET-overexpressing Non-Small Cell Lung Cancers: Time to Move on to Better Biomarkers?
Translational Lung Cancer Research - Hong Kong
doi 10.21037/tlcr.2017.08.07
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2017
Authors
Unknown
Publisher
AME Publishing Company
